BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fish and Richardson
Colorcon
Federal Trade Commission
Johnson and Johnson
Accenture
Queensland Health
UBS
Medtronic
Express Scripts

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,030,632

« Back to Dashboard

Summary for Patent: 5,030,632
Title: Low dose temazepam
Abstract:This invention relates to a hard gelatin capsule containing no more than 5 to 10 milligrams of crystalline temazepam and its use in the treatment of transient insomnia.
Inventor(s): Sterling; William R. (Pine Brook, NJ)
Assignee: Sandoz Pharm. Corp. (E. Hanover, NJ)
Application Number:07/569,787
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 5,030,632

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,030,632

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium 1000318 ➤ Subscribe
Canada 1302886 ➤ Subscribe
Switzerland 673947 ➤ Subscribe
Germany 3731840 ➤ Subscribe
France 2604091 ➤ Subscribe
United Kingdom 2195242 ➤ Subscribe
United Kingdom 8722205 ➤ Subscribe
Italy 1221509 ➤ Subscribe
Italy 8748408 ➤ Subscribe
Japan S63101325 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Chubb
Teva
Deloitte
Argus Health
Merck
US Army
Healthtrust
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot